Insulet Q4 Earnings Preview

Insulet PODD releases its next round of earnings Wednesday. Get the latest predictions in Benzinga's essential guide to the company's Q4 earnings report.

Earnings and Revenue

Insulet's per-share loss will be near 8 cents on sales of $125.15 million, according to Wall Street analysts.

Insulet EPS in the same period a year ago came in at a loss of 16 cents per share. Sales were $103 million. If the company were to match the consensus estimate, earnings would be down 50 percent. Sales would be up 20.83 percent from the year-ago period.

In comparison to analyst estimates in the past, here's how the company's reported EPS stacks up:

 

Quarter Q3 2017 Q2 2017 Q1 2017 Q4 2016
EPS Estimate -0.1 -0.13 -0.16 -0.05
EPS Actual -0.04 -0.13 -0.17 -0.16


Stock Performance

Over the last 52-week period, shares of Insulet are up 76.72 percent. Analysts have adjusted their estimates higher for EPS and revenues over the past 90 days. The average rating by analysts on Insulet stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days.

Conference Call

Insulet is scheduled to hold a conference call at 4:30 p.m. ET and it can be accessed here.

Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPreviewsTrading IdeasEarnings Previews
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...